Answers are grounded in this paper and cite their sources.
The reclassification rate during surveillance is not equally distributed across time or risk groups. Due to misclassification at diagnosis the reclassification rate in very low and low risk groups is similar in the first 2 years but differs significantly beyond 2 years. The risk of reclassification decreases with time for each nonreclassifying biopsy beyond 2 years.
No takes yet. Share an insight, caveat, or question.
Alam et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: